BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
December 07, 2011 at 15:30 PM EST
Neoprobe to Present at the Oppenheimer & Co. 22nd Annual Healthcare Conference

Neoprobe Corporation (NYSE Amex: NEOP) today announced that Dr. Mark Pykett, President and Chief Executive Officer, will participate at the Oppenheimer & Co. 22nd Annual Healthcare Conference. Dr. Pykett will provide an update of the Company and its development programs followed by a question and answer period with institutional investors on December 13, 2011 at 10:50 AM EST in New York City.

Investors and the public are invited to listen to a live webcast of Dr. Pykett’s presentation at http://www.veracast.com/webcasts/opco/healthcare2011/87109352.cfm. Following the conference, the webcast will be archived for approximately 30 days.

About Neoprobe

Neoprobe Corporation (NYSE Amex: NEOP) is a biomedical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. Neoprobe is actively developing two radiopharmaceutical agent platforms – Lymphoseek® and RIGScanTM CR – to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making and ultimately patient care. Neoprobe’s strategy is to deliver superior growth and shareholder return by bringing to market novel radiopharmaceutical agents and advancing the Company’s pipeline through selective acquisitions, global partnering and commercialization efforts. For more information, please visit www.neoprobe.com.

Contacts:

Neoprobe Corporation
Brent Larson, 614-822-2330
Sr. VP & CFO
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here